The data presented are the first to shed light onto the leukocyte-enriched expression of PI3KCD. Further investigations are needed to identify which TF-binding sites are critical in driving PIK3CD gene expression and whether cells of non-leukocyte origin, such as breast cancer cells, are able to utilize this putative promoter. The gene discussed is TF; the disease is breast carcinoma.